Niagen Bioscience Inc (NAGE)

Finanzdaten der Niagen Bioscience Inc-Aktie (NAGE)

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
Revenues	5.37%29.79	31.47	33.84	33.99	31.12
Cost Of Revenue	8.93%10.47	11.50	12.14	12.06	10.89
Gross Profit	3.31%19.31	19.98	21.70	21.93	20.23
	1.16%18.61	18.40	17.62	17.69	17.04
Research and Development	2.16%1.51	1.48	1.71	1.80	1.57
Operating Income/Loss	55.58%0.70	1.58	4.09	4.24	3.19
Income/Loss From Continuing Operations Before Tax	84.13%1.07	6.74	4.42	4.80	3.74
Income Tax Expense/Benefit	74.58%0.11	0.42	0.29	0.22	0.13
	84.76%0.96	6.32	4.13	4.58	3.61
Attributable To Parent	84.76%0.96	6.32	4.13	4.58	3.61
Basic Average Shares	0.74%79.32	79.92	0.23	79.78	79.25
Diluted Average Shares	2.44%82.50	84.57	-0.05	86.62	86.24
Basic Earnings Per Share	87.50%0.01	0.08	0.05	0.06	0.05
Diluted Earnings Per Share	85.71%0.01	0.07	0.05	0.05	0.04